arginine bpc-157 pharmaceutical-grade salt BPC-157 erectile dysfunction: What the limited evidence actually shows Superpower

Our non-surgical treatment options allow you to move forward with less pain and minimal downtime

Table 4)

O'Leary, F., & Samman, S

available only through 503A compounding pharmacies under physician supervision Typical research dose range / 200-800 mcg/day subcutaneously, cycled 4-8 weeks Known lethal dose (LD50) / Not established in any species studied to date Rodent acute toxicity ceiling / No mortality observed at doses exceeding 10 mg/kg intraperitoneally Most reported excess-dose symptoms / Nausea, lightheadedness, flushing, injection-site irritation Organ toxicity at supratherapeutic doses / Not demonstrated in published preclinical literature Antidote availability / No specific antidote exists